Clinical Trial Update: Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of ranolazine for pulmonary hypertension associated with diastolic left ventricular dysfunction completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• Ranolazine (Ranexa) (Ranolazine)

Snippet

Sponsor: Boston University | Conditions: Pulmonary Hypertension, Diastolic Left Ventricular Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2017-05-17